Aller au contenu principal
Profil bibliographique

Arthur J. Berkson

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
153Citations signalées
0Affiliations récentes

Les domaines associés

Folate and B Vitamins ResearchBiochemical and Molecular ResearchBiochemical Acid Research StudiesLymphoma Diagnosis and TreatmentCardiac electrophysiology and arrhythmias

Les publications récentes

Accès ouvert 2025 article OpenAlex

Multivitamins After Myocardial Infarction in Patients With Diabetes

Francisco Ujueta, Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas‐Acién et autres

Importance: In 2013, the Trial to Assess Chelation Therapy (TACT) reported that in 1708 patients with stable coronary disease and prior myocardial infarction (MI), oral multivitamins and multiminerals (OMVMs), in a factorial design with edetate disodium (EDTA) chelation therapy, did not reduce …

us, ca (code pays fourni par la source)

4 citations JAMA Internal Medicine
Accès ouvert 2024 article OpenAlex

Edetate Disodium–Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes

Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas‐Acién, Robin Boineau et autres

Importance: In 2013, the Trial to Assess Chelation Therapy (TACT) reported that edetate disodium (EDTA)-based chelation significantly reduced cardiovascular disease (CVD) events by 18% in 1708 patients with a prior myocardial infarction (MI). Objective: To replicate the finding of TACT in individuals …

us, ca (code pays fourni par la source)

28 citations JAMA
Accès ouvert 2009 article OpenAlex

Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases

Burton M. Berkson, Daniel Rubin, Arthur J. Berkson

The authors, in a previous article, described the long-term survival of a man with pancreatic cancer and metastases to the liver, treated with intravenous alpha-lipoic acid and oral low-dose naltrexone (ALA/N) without any adverse effects. He is alive and well 78 months …

us (code pays fourni par la source)

54 citations Integrative Cancer Therapies
Accès ouvert 2007 article OpenAlex

Reversal of Signs and Symptoms of a B-Cell Lymphoma in a Patient Using Only Low-Dose Naltrexone

Burton M. Berkson, Daniel Rubin, Arthur J. Berkson

T.M. is a 61-year-old man with a medical history significant for type 2 diabetes mellitus, rheumatoid arthritis, hypothyroidism, and hyperlipidemia. For these, he had been prescribed (via physicians other than the authors) levothyroxine, metformin, glyburide, and fenofibrate. Regarding the diagnosis of follicular …

us (code pays fourni par la source)

23 citations Integrative Cancer Therapies
Accès ouvert 2006 article OpenAlex

The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol

Burton M. Berkson, Daniel Rubin, Arthur J. Berkson

The authors describe the long-term survival of a patient with pancreatic cancer without any toxic adverse effects. The treatment regimen includes the intravenous alpha-lipoic acid and low-dose naltrexone (ALA-N) protocol and a healthy lifestyle program. The patient was told by a reputable …

us (code pays fourni par la source)

44 citations Integrative Cancer Therapies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.